F5, Inc. CapEx increased by 88.7% to $18.35M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 74.7%, from $10.50M to $18.35M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 9.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.44M | $7.12M | $10.56M | $5.23M | $9.33M | $8.51M | $13.10M | $10.69M | $15.01M | $15.38M | $9.05M | $9.46M | $5.85M | $6.06M | $8.07M | $10.50M | $8.54M | $16.14M | $9.72M | $18.35M |
| QoQ Change | — | -24.6% | +48.4% | -50.5% | +78.4% | -8.8% | +54.0% | -18.4% | +40.4% | +2.5% | -41.2% | +4.5% | -38.1% | +3.6% | +33.2% | +30.1% | -18.7% | +88.9% | -39.8% | +88.7% |
| YoY Change | — | — | — | — | -1.3% | +19.5% | +24.0% | +104.5% | +61.0% | +80.8% | -31.0% | -11.5% | -61.0% | -60.6% | -10.8% | +11.1% | +46.1% | +166.4% | +20.4% | +74.7% |